IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
In 35 patients with hypertrophic cardiomyopathy, the effects of ivabradine (15 mg/d) and atenolol (50 mg/d) on physical stress tolerability (veloergometry test results) were investigated. Ivabradine and atenolol therapy was associated with increased test time: +1,5 minutes (p<0,01) and +2,4 m...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2010-02-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1421 |
id |
doaj-de75f26e6aa34e498f1c60bc412344b7 |
---|---|
record_format |
Article |
spelling |
doaj-de75f26e6aa34e498f1c60bc412344b72021-07-28T14:02:13Zrus«FIRMA «SILICEA» LLC Российский кардиологический журнал1560-40712618-76202010-02-010159641209IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHYP. Kh. Dzhanashiya0I. V. Markelova1N. S. Krylova2E. V. Avdeeva3V. A. Nazarenko4S. A. Nikolenko5Кафедра общей терапии факультета усовершенствования врачей РГМУ Росздрава, МоскваКафедра общей терапии факультета усовершенствования врачей РГМУ Росздрава, МоскваКафедра общей терапии факультета усовершенствования врачей РГМУ Росздрава, МоскваКафедра общей терапии факультета усовершенствования врачей РГМУ Росздрава, МоскваКафедра общей терапии факультета усовершенствования врачей РГМУ Росздрава, МоскваКафедра общей терапии факультета усовершенствования врачей РГМУ Росздрава, МоскваIn 35 patients with hypertrophic cardiomyopathy, the effects of ivabradine (15 mg/d) and atenolol (50 mg/d) on physical stress tolerability (veloergometry test results) were investigated. Ivabradine and atenolol therapy was associated with increased test time: +1,5 minutes (p<0,01) and +2,4 minutes (p<0,01), respectively. Both medications prevented angina attacks and paradoxical blood pressure drop during the physical stress test.https://russjcardiol.elpub.ru/jour/article/view/1421hypertrophic cardiomyopathyivabradineatenolol |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
P. Kh. Dzhanashiya I. V. Markelova N. S. Krylova E. V. Avdeeva V. A. Nazarenko S. A. Nikolenko |
spellingShingle |
P. Kh. Dzhanashiya I. V. Markelova N. S. Krylova E. V. Avdeeva V. A. Nazarenko S. A. Nikolenko IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY Российский кардиологический журнал hypertrophic cardiomyopathy ivabradine atenolol |
author_facet |
P. Kh. Dzhanashiya I. V. Markelova N. S. Krylova E. V. Avdeeva V. A. Nazarenko S. A. Nikolenko |
author_sort |
P. Kh. Dzhanashiya |
title |
IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY |
title_short |
IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY |
title_full |
IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY |
title_fullStr |
IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY |
title_full_unstemmed |
IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY |
title_sort |
ivabradin and atenolol effectiveness comparison in patients with hypertrophic cardiomyopathy |
publisher |
«FIRMA «SILICEA» LLC |
series |
Российский кардиологический журнал |
issn |
1560-4071 2618-7620 |
publishDate |
2010-02-01 |
description |
In 35 patients with hypertrophic cardiomyopathy, the effects of ivabradine (15 mg/d) and atenolol (50 mg/d) on physical stress tolerability (veloergometry test results) were investigated. Ivabradine and atenolol therapy was associated with increased test time: +1,5 minutes (p<0,01) and +2,4 minutes (p<0,01), respectively. Both medications prevented angina attacks and paradoxical blood pressure drop during the physical stress test. |
topic |
hypertrophic cardiomyopathy ivabradine atenolol |
url |
https://russjcardiol.elpub.ru/jour/article/view/1421 |
work_keys_str_mv |
AT pkhdzhanashiya ivabradinandatenololeffectivenesscomparisoninpatientswithhypertrophiccardiomyopathy AT ivmarkelova ivabradinandatenololeffectivenesscomparisoninpatientswithhypertrophiccardiomyopathy AT nskrylova ivabradinandatenololeffectivenesscomparisoninpatientswithhypertrophiccardiomyopathy AT evavdeeva ivabradinandatenololeffectivenesscomparisoninpatientswithhypertrophiccardiomyopathy AT vanazarenko ivabradinandatenololeffectivenesscomparisoninpatientswithhypertrophiccardiomyopathy AT sanikolenko ivabradinandatenololeffectivenesscomparisoninpatientswithhypertrophiccardiomyopathy |
_version_ |
1721269601822572544 |